Revolution (mites)

Selamectin, marketed under the brand names Revolution and Stronghold, represents one of the most important and frequently prescribed medications in hedgehog medicine, particularly for the treatment and prevention of mite infestations. This macrocyclic lactone antiparasitic belongs to the avermectin family of compounds and works by interfering with chloride channel function in the nervous system of parasites, causing paralysis and death of the target organisms while maintaining an excellent safety profile in mammalian hosts. The medication has become the gold standard for treating the common and often debilitating mite infestations that affect pet hedgehogs worldwide.

The development of selamectin for veterinary use represented a significant advancement in parasite control, offering broad-spectrum activity against both internal and external parasites through a convenient topical application. Originally developed and approved for use in dogs and cats, selamectin has found extensive extra-label application in exotic small mammals, where its safety profile and ease of administration have made it invaluable for exotic veterinary practitioners. The medication's ability to treat multiple parasite types simultaneously while requiring only monthly application has revolutionized parasite management in hedgehog medicine.

Selamectin is available as a topical solution packaged in single-dose applicator tubes designed for easy administration. The medication comes in various concentrations formulated for different body weights, though hedgehogs typically require the smallest available size due to their diminutive body mass. The topical formulation is applied to the skin, where it is absorbed and distributed throughout the body via the bloodstream, providing systemic protection against parasites while also maintaining effective concentrations in the skin and sebaceous glands where external parasites reside.

The safety and efficacy of selamectin in hedgehogs has been well-documented through years of clinical use by exotic veterinary specialists, making it the treatment of choice for mite infestations in this species. When used at appropriate doses under veterinary supervision, selamectin provides reliable parasite control with minimal risk of adverse effects. The medication's favorable safety margin in hedgehogs, combined with its broad-spectrum antiparasitic activity and convenient monthly dosing schedule, has established it as an essential component of hedgehog healthcare protocols worldwide.

The primary indication for selamectin use in hedgehogs is the treatment and prevention of mite infestations, which represent one of the most common health problems encountered in pet hedgehogs. Caparinia tripilis, the hedgehog quill mite, is the most frequently diagnosed external parasite in captive hedgehogs and causes significant morbidity including quill loss, skin irritation, crusty dermatitis, and intense pruritus that severely impacts quality of life. Selamectin provides highly effective treatment for these infestations, typically resolving clinical signs within two to four weeks of initiating therapy with appropriate repeat treatments.

Beyond quill mites, selamectin demonstrates excellent efficacy against other ectoparasites that may affect hedgehogs, including sarcoptic mange mites, ear mites, and various other mite species that can cause dermatological disease. The medication's broad-spectrum activity makes it valuable for treating mixed infestations or cases where the specific mite species has not been definitively identified. This versatility is particularly important in hedgehog medicine, where multiple parasite species may be present simultaneously and accurate species identification may require specialized diagnostic techniques not always readily available.

Selamectin also provides protection against certain internal parasites, though this application is less commonly emphasized in hedgehog medicine compared to ectoparasite control. The medication has activity against some intestinal parasites and heartworms, though the clinical significance of these indications varies depending on geographic location and individual hedgehog exposure risk. Exotic veterinarians may consider these additional protective benefits when developing comprehensive parasite prevention protocols for hedgehogs in endemic areas.

Prophylactic use of selamectin has become increasingly common in hedgehog husbandry, with many exotic veterinarians recommending regular preventive treatments for hedgehogs at risk of mite exposure. This is particularly relevant for hedgehogs obtained from breeding facilities, pet stores, or rescue organizations where mite infestations are common, as well as for hedgehogs housed with other animals that may serve as mite reservoirs. Monthly preventive application can help maintain mite-free status and prevent the development of clinical infestations.

The choice of selamectin over alternative antiparasitic medications in hedgehogs is based on its superior safety profile in this species compared to some other commonly used antiparasitics. Unlike certain other avermectins and some organophosphate or pyrethroid products, selamectin has demonstrated consistent safety in hedgehogs when used at appropriate doses, making it the preferred first-line treatment for most mite infestations. This excellent safety record, combined with the convenience of topical administration and the established efficacy against the most common hedgehog parasites, supports selamectin's position as the treatment of choice for parasitic conditions in hedgehog medicine.

Dosing of selamectin in hedgehogs requires careful calculation and veterinary guidance due to the significant difference between hedgehog body weights and the species for which commercial formulations were designed. Exotic veterinarians experienced with hedgehog medicine have established dosing protocols based on clinical experience and extrapolation from other species, though specific doses should always be determined by the prescribing veterinarian based on individual patient assessment. The medication's wide safety margin provides some flexibility in dosing, but accurate weight measurement and appropriate dose selection remain essential for optimal outcomes.

The route of administration for selamectin is exclusively topical, with the medication applied directly to the skin in an area where the hedgehog cannot easily reach to groom or lick. The recommended application site in hedgehogs is typically the skin at the back of the neck or between the shoulder blades, where the quills part naturally and provide access to the underlying skin. Care must be taken to ensure the medication contacts the skin rather than being applied only to the quills, as dermal absorption is necessary for the medication to achieve therapeutic systemic concentrations.

Treatment frequency for active mite infestations typically involves repeat applications at intervals determined by the prescribing veterinarian, with protocols commonly calling for treatments every two to four weeks until the infestation is resolved. The treatment duration depends on the severity of infestation, the specific parasite involved, and the individual patient's response to therapy. Most uncomplicated mite infestations respond well to two to three treatments, though severe or chronic infestations may require more prolonged therapy and concurrent environmental decontamination measures.

Species-specific dosing considerations in hedgehogs reflect their unique physiology and relatively small body size compared to cats and dogs. The smallest commercially available selamectin tube is often more than needed for a single hedgehog treatment, and exotic veterinarians may provide guidance on dividing doses appropriately or may dispense pre-measured amounts from larger containers. Accurate dosing is important both to ensure therapeutic efficacy and to avoid potential toxicity from excessive administration.

Compounding of selamectin into more concentrated or diluted formulations is generally not necessary due to the availability of appropriate commercial products and the medication's favorable safety profile allowing some flexibility in dosing. However, exotic veterinarians may occasionally prepare diluted solutions for very small patients or when precise micro-dosing is required. Any compounded formulations should be prepared by licensed veterinary pharmacies following appropriate stability and sterility guidelines.

Administration tips for hedgehog owners include allowing the hedgehog to unroll naturally before application, applying the medication quickly and efficiently to minimize stress, and preventing the hedgehog from rolling or rubbing immediately after application to avoid removing or spreading the medication inappropriately. Environmental treatment concurrent with topical therapy is often recommended for severe infestations, including thorough cleaning and disinfection of the hedgehog's enclosure and replacement of bedding materials that may harbor mites or eggs. Follow-up veterinary examinations are important to confirm resolution of the infestation and determine when treatment can be discontinued.

Selamectin is generally very well-tolerated in hedgehogs, with adverse effects being uncommon when the medication is used at appropriate doses under veterinary supervision. The excellent safety profile of selamectin in this species is one of the primary reasons for its widespread adoption as the treatment of choice for hedgehog mite infestations. Most hedgehogs receive selamectin treatments without experiencing any noticeable adverse effects, and the medication has been used safely in hedgehogs of various ages and health conditions.

The most commonly reported side effect associated with selamectin application in hedgehogs is temporary local irritation at the application site, which may manifest as mild redness, flaking, or transient hair loss in the area where the medication was applied. These local reactions are typically mild and self-limiting, resolving within a few days to a week without requiring specific treatment. The incidence of local reactions can be minimized by ensuring proper application technique and avoiding excessive amounts of medication at a single site.

Gastrointestinal effects including decreased appetite, mild lethargy, or temporary changes in fecal consistency have been occasionally reported following selamectin administration in hedgehogs, though these effects are uncommon and typically transient. These systemic effects, when they occur, generally resolve within twenty-four to forty-eight hours without specific intervention. Hedgehogs experiencing these effects should be monitored closely, and veterinary consultation is recommended if symptoms persist or worsen.

Serious adverse effects from selamectin are rare in hedgehogs but may include neurological signs such as tremors, ataxia, or excessive salivation if significant overdose occurs. The wide safety margin of selamectin makes clinical toxicity unlikely at recommended doses, but these signs warrant immediate veterinary attention if observed. Hedgehogs with compromised health status, concurrent illness, or those receiving other medications may potentially be at increased risk for adverse effects and should be monitored more closely during treatment.

Owners should contact their exotic veterinarian promptly if their hedgehog exhibits any concerning signs following selamectin application, including but not limited to persistent lethargy, complete anorexia lasting more than twenty-four hours, significant skin reactions at the application site, any neurological abnormalities, or general deterioration in condition. While serious reactions are uncommon, prompt veterinary evaluation ensures appropriate management of any treatment-related complications and allows for adjustment of the treatment protocol if necessary.

Selamectin should not be used in hedgehogs with known hypersensitivity to selamectin or other avermectin compounds, though true allergic reactions to these medications are rare. Any hedgehog that has previously experienced an adverse reaction to selamectin or related macrocyclic lactones should not receive subsequent treatments without careful veterinary evaluation and consideration of alternative antiparasitic options. Documentation of any previous adverse reactions should be maintained in the patient's medical record to guide future treatment decisions.

Caution is warranted when considering selamectin use in hedgehogs with certain concurrent medical conditions that may affect drug metabolism or increase sensitivity to medication effects. Hedgehogs with significant hepatic impairment may have altered drug clearance and could potentially be at increased risk for adverse effects, though specific studies in hedgehogs with liver disease are limited. Similarly, hedgehogs with severe systemic illness, debilitation, or compromised immune function may warrant closer monitoring during antiparasitic treatment.

The use of selamectin in pregnant or nursing hedgehogs has not been extensively studied, and caution is generally advised in these situations. While selamectin has been used safely in pregnant dogs and cats at recommended doses, the specific safety profile in pregnant hedgehogs is not well-characterized. Exotic veterinarians must weigh the benefits of treating active parasitic infestations against potential risks to developing fetuses or nursing hoglets when making treatment decisions for breeding or lactating hedgehogs.

Very young hedgehogs may require modified dosing protocols or alternative treatments, as pharmacokinetic parameters may differ in neonatal and juvenile animals compared to adults. Selamectin has been used successfully in young hedgehogs, but treatment of hoglets should be undertaken with appropriate veterinary guidance and careful attention to accurate weight-based dosing. The minimum age for safe selamectin administration in hedgehogs should be determined by the prescribing veterinarian based on individual patient assessment.

Selamectin drug interactions in hedgehogs have not been extensively studied, and information is largely extrapolated from data in other species combined with clinical experience in exotic veterinary practice. Generally, selamectin is considered to have a favorable interaction profile and can be safely used in combination with many other medications commonly prescribed for hedgehogs. However, exotic veterinarians should be informed of all medications, supplements, and treatments a hedgehog is receiving to appropriately assess potential interaction risks.

Concurrent use of selamectin with other antiparasitic medications warrants careful consideration, as combining multiple antiparasitic agents may increase the risk of toxicity without providing additional therapeutic benefit. In particular, the combination of selamectin with other macrocyclic lactones such as ivermectin or moxidectin should generally be avoided due to overlapping mechanisms of action and potential for additive effects on chloride channel function. If combination antiparasitic therapy is deemed necessary, treatments should be appropriately spaced and patients monitored closely for adverse effects.

Medications that affect hepatic metabolism may theoretically alter selamectin clearance, though the clinical significance of such interactions in hedgehogs is not well-established. Drugs that inhibit cytochrome P450 enzymes might potentially increase selamectin concentrations, while enzyme inducers could theoretically decrease efficacy. Hedgehogs receiving chronic therapy with medications known to affect hepatic metabolism should be monitored appropriately when selamectin is added to their treatment regimen.

Selamectin can generally be used safely in hedgehogs receiving concurrent treatment for other medical conditions, including antibiotics, anti-inflammatory medications, and supportive care therapies. The medication does not have significant interactions with most commonly used veterinary pharmaceuticals, making it suitable for use in hedgehogs with multiple concurrent health issues requiring polypharmacy. Nevertheless, comprehensive medication review by an exotic veterinarian remains important whenever new treatments are initiated to identify any potential interaction concerns specific to the individual patient's situation.

⚠️ EXTRA-LABEL USE WARNING: Selamectin is not FDA-approved for use in hedgehogs and is used exclusively on an extra-label basis in this species. All treatment decisions should be made by a qualified exotic veterinarian familiar with hedgehog medicine, and owners should follow veterinary guidance precisely regarding dosing and administration. The successful use of selamectin in hedgehogs relies on appropriate veterinary oversight and adherence to established protocols developed through clinical experience in this species.

Species-specific warnings for hedgehogs include the importance of accurate weight measurement before dosing, as hedgehog body weights can vary significantly and many hedgehogs are smaller than the minimum weight for which commercial selamectin products are formulated. Overdosing can occur if weight is overestimated or if products intended for larger animals are used without appropriate dose adjustment. Owners should ensure their hedgehog is weighed accurately at each treatment, ideally at the veterinary clinic using an appropriately calibrated scale.

Monitoring requirements during selamectin therapy include observation for resolution of parasitic infection as evidenced by decreased scratching, improved skin condition, reduced quill loss, and overall improvement in the hedgehog's demeanor and activity level. Failure to respond to treatment may indicate misdiagnosis, severe infestation requiring prolonged therapy, environmental recontamination, or rarely, resistance to the medication. Follow-up veterinary examination is recommended to confirm treatment success and identify any cases requiring modified treatment approaches.

Human safety considerations when handling selamectin include avoiding direct skin contact with the medication, washing hands thoroughly after application, and keeping treated hedgehogs away from young children until the application site has dried completely. While selamectin has a favorable safety profile in humans, direct exposure should be minimized as a general precautionary measure. Individuals with known sensitivity to avermectin compounds should take particular care when handling the medication.

Storage during treatment should ensure that selamectin products are kept in their original packaging, protected from light and extreme temperatures, and stored out of reach of children and pets. Partially used tubes should generally not be stored for future use unless specifically advised by the prescribing veterinarian, as product stability after opening may be compromised. Environmental decontamination measures concurrent with hedgehog treatment are important for preventing reinfestation and should be discussed with the treating veterinarian as part of a comprehensive mite management plan.

Selamectin should be stored according to manufacturer recommendations to maintain product stability and efficacy throughout its shelf life. The medication should be kept in its original packaging at controlled room temperature, typically between fifteen and thirty degrees Celsius, and protected from excessive heat, cold, and direct sunlight. Proper storage ensures that the medication retains its full potency and safety profile when administered to hedgehog patients.

The shelf life of selamectin products is indicated on the packaging and should be checked before each use to ensure the medication has not expired. Expired products should not be used and should be disposed of appropriately through veterinary clinic take-back programs or community pharmaceutical disposal facilities. Using expired medication may result in reduced efficacy against parasites and could potentially pose safety concerns due to degradation products.

Safe handling of selamectin requires attention to personal protective measures including avoiding direct skin contact, washing hands thoroughly after application, and taking care not to contaminate food preparation surfaces or other household items. The medication should be applied in a well-ventilated area, and any spills should be cleaned up promptly following appropriate safety procedures. Disposal of empty applicator tubes and any unused medication should follow local regulations for pharmaceutical waste disposal, and these materials should not be discarded in regular household trash or flushed down drains where they could enter water systems and potentially affect aquatic organisms.

Hedgehogs represent the primary small mammal species for which selamectin is prescribed specifically for mite control, as mite infestations are exceptionally common in this species and selamectin has proven highly effective and safe for this application. The medication has become the standard of care for hedgehog mite infestations based on years of clinical experience demonstrating consistent efficacy against Caparinia tripilis and other mite species with minimal adverse effects. Hedgehog owners should work closely with exotic veterinarians experienced in hedgehog medicine to ensure appropriate diagnosis and treatment of suspected mite infestations.

While this information focuses on hedgehog applications, selamectin is also used in other small mammal species including ferrets, where it is commonly prescribed for flea and heartworm prevention, and occasionally in rabbits and rodents for ectoparasite control. The safety and efficacy profile may vary between species, and dosing protocols differ based on body size, metabolism, and species-specific sensitivity to avermectin compounds. Treatment of any small mammal species with selamectin should be undertaken only under appropriate veterinary guidance.

For hamsters, gerbils, mice, rats, guinea pigs, and chinchillas, selamectin may be considered for mite treatment in some cases, though these species have different ectoparasite spectrums than hedgehogs and may require different treatment approaches. The safety of selamectin in these species is generally acceptable when used at appropriate doses, though some species may be more sensitive to avermectin compounds than others. Veterinary consultation is essential before using selamectin in any small mammal species.

Sugar gliders and other exotic small mammals may occasionally receive selamectin for parasite control, though experience with the medication in these species is more limited than in hedgehogs. Species-specific considerations including body size, metabolism, and parasite susceptibility must be evaluated when considering selamectin therapy in less commonly treated small mammal species. Exotic veterinarians with experience treating specific small mammal species are best positioned to make appropriate treatment recommendations for parasitic conditions in these animals.

Ivermectin represents an alternative macrocyclic lactone antiparasitic that has been used for mite treatment in hedgehogs, though selamectin is generally preferred due to its more favorable safety profile and convenient topical administration. Ivermectin can be administered orally or by injection and may be considered in cases where selamectin is unavailable, ineffective, or contraindicated. However, ivermectin has a narrower safety margin than selamectin and requires more precise dosing to avoid potential toxicity, making veterinary supervision particularly important when this alternative is used.

Moxidectin is another macrocyclic lactone with antiparasitic activity that has occasionally been used in exotic small mammals, though experience with this medication in hedgehogs is more limited than with selamectin or ivermectin. Moxidectin has a longer duration of action than some other avermectins, which may be advantageous in certain treatment scenarios. As with other antiparasitics, moxidectin use in hedgehogs represents extra-label application and should be undertaken only under veterinary guidance.

For hedgehogs with contraindications to avermectin-class medications or in cases of treatment failure with selamectin, alternative approaches may include pyrethrin-based products designed for small mammals, though these generally require more frequent application and may be less effective than macrocyclic lactones for established mite infestations. Fipronil has been used in some small mammal species but has variable safety in hedgehogs and is not generally recommended as a first-line treatment. The selection of alternative antiparasitic medications should be guided by exotic veterinary expertise and individual patient considerations, with selamectin remaining the preferred treatment for most hedgehog mite infestations when no contraindications exist.